Based on results demonstrating the immunostimulatory role of IL-18, the authors concluded that the balance between the effects of IL-18-mediated antitumor immunity and its promotion of cancerous cell invasion could have favorable effects in the host by blocking NF-κB expression in cancer cells. This evidence concerns the gene NFKB1 and cancer.